Indication
For the treatment of adult patients with recurrent or metastatic cervical cancer (r/m CC) with disease progression on or after systemic therapy.
Medicine details
- Medicine name:
- tisotumab vedotin (Tivdak)
- SMC ID:
- SMC2949
- Pharmaceutical company
- Genmab
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC